APA (7th ed.) Citation

MP, M., A, T., D, F., F, B., M, R., C, B., . . . C, M. (2000). Severe cognitive impairment in DMD: Obvious clinical indication for Dp71 isoform point mutation screening. European journal of human genetics : EJHG, 8(7), 552. https://doi.org/10.1038/sj.ejhg.5200488

Chicago Style (17th ed.) Citation

MP, Moizard, Toutain A, Fournier D, Berret F, Raynaud M, Billard C, Andres C, and Moraine C. "Severe Cognitive Impairment in DMD: Obvious Clinical Indication for Dp71 Isoform Point Mutation Screening." European Journal of Human Genetics : EJHG 8, no. 7 (2000): 552. https://doi.org/10.1038/sj.ejhg.5200488.

MLA (9th ed.) Citation

MP, Moizard, et al. "Severe Cognitive Impairment in DMD: Obvious Clinical Indication for Dp71 Isoform Point Mutation Screening." European Journal of Human Genetics : EJHG, vol. 8, no. 7, 2000, p. 552, https://doi.org/10.1038/sj.ejhg.5200488.